• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Legislation allows controlled drugs supply without prescription

30th April 2020 by PIP editor Leave a Comment

 

The Government has passed legislation which allows pharmacists to provide controlled drugs to patients who have previously been prescribed them, without the need for a new prescription.

 

The legislation enables patients to continue to receive access to the medicines they need directly from a pharmacist, under exceptional circumstances. These include the closure of GP practices or other services in an area because of COVID-19, and where the patient’s health is at risk. To maintain treatment and reduce harm, it also allows pharmacists to vary in the interval between each time the medicine can be supplied, after consultation with the prescribing service.

 

The legislation can only be activated by an announcement from the Secretary of State for Health and Social Care. It will only apply in a specific location and for a limited time. Once the issue triggering the announcement is resolved, the new measures will be withdrawn and the usual practice will apply.

 

RPS President Sandra Gidley said:

 

“We welcome this legislation to maintain patient access to treatment when the usual means of prescribing and accessing it are unavailable. This will bring relief to patients needing ongoing treatment for palliative care or substance misuse therapy.

 

“The flexibilities the legislation provides empowers pharmacists to provide the right care for patients during the pandemic.

 

“We are continuing to talk to the Government and the NHS about how frontline pharmacists are playing a critical role supporting patients and vulnerable groups during COVID-19.

 

“Now the legislation has been published, we will shortly provide professional guidance for pharmacists who may need to supply controlled drugs under the new measures.”

 

 

Share this:

  • Tweet
  • WhatsApp
  • Telegram
  • Email

Related

Next article  Moderna Covid-19 vaccine approved by UK regulator

Filed Under: News Tagged With: Controlled drugs, Legislation

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Community pharmacy central to tackling hepatitis C

It is difficult to know how to ask a patient if they can read

No national Scottish pharmacy flu service a missed opportunity

Community pharmacists can identify high-risk asthmatic patients

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.